Former Johnson & Johnson exec joins CorneaGen board

CorneaGen announced Thursday that Tom Frinzi, formerly worldwide president of Johnson& Johnson Vision, joined its board of directors. Seattle-based CorneaGen focuses on developing technologies to cure corneal blindness by 2040 and provides donor tissues for cornea transplants. Frinzi, with more than 35 years of experience in ophthalmology, will lead CorneaGen’s board as executive chair, replacing William Link, who will remai n on the board. “Tom’s deep experience in bringing ophthalmology…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news